Skip to main content
SpringerLink
Log in
Book cover

Cornea and External Eye Disease pp 1–12Cite as

Immune Privilege of Corneal Allografts

  • Chapter

  • 1370 Accesses

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Bigger SL (1837) An inquiry into the possibility of transplanting the cornea with the view of relieving blindness (hitherto deemed incurable) caused by several diseases of that structure. Dublin J Med Sci 11:408–447

    Google Scholar 

  2. Kissam R (1844) Ceratoplastice in man. N Y J Med 2: 281–289

    Google Scholar 

  3. May CH (1887) Transplantation of a rabbit's eye into the human orbit. Arch Ophthalmol 16:47–53

    Google Scholar 

  4. Niederkorn JY (2007) Immune mechanisms of corneal allograf rejection. Curr Eye Res 32:1005–1016

    Article  CAS  PubMed  Google Scholar 

  5. Niederkorn JY (2003) The immune privilege of corneal grafts. J Leukoc Biol 74:167–171

    Article  CAS  PubMed  Google Scholar 

  6. Group CCTSR (1992) The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 110:1392–1403

    Google Scholar 

  7. Waldock A, Cook SD (2000) Corneal transplantation: how successful are we? Br J Ophthalmol 84:813–815

    Article  CAS  PubMed  Google Scholar 

  8. Medawar PB (1948) Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58–69

    CAS  PubMed  Google Scholar 

  9. Streilein JW (2003) New thoughts on the immunology of corneal transplantation. Eye 17:943–948

    Article  CAS  PubMed  Google Scholar 

  10. Williams KA, Muehlberg SM, Lewis RF et al (1997) Long-term outcome in corneal allotransplantation. The Australian corneal graft registry. Transplant Proc 29:983

    Article  CAS  PubMed  Google Scholar 

  11. George AJ, Larkin DF (2004) Corneal transplantation: the forgotten graft. Am J Transplant 4:678–685

    Article  CAS  PubMed  Google Scholar 

  12. Vail A, Gore SM, Bradley BA et al (1994) Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation 58:1210–1216

    CAS  PubMed  Google Scholar 

  13. Boisgerault F, Liu Y, Anosova N et al (2001) Role of cd4(+) and cd8(+) t cells in allorecognition: lessons from corneal transplantation. J Immunol 167:1891–1899

    CAS  PubMed  Google Scholar 

  14. Nicholls SM, Bradley BA, Easty DL (1995) Non-MHC antigens and their relative resistance to immunosuppres-sion after corneal transplantation. Eye 9(Pt 2):208–214

    PubMed  Google Scholar 

  15. Sonoda Y, Streilein JW (1992) Orthotopic corneal transplantation in mice—evidence that the immunogenetic rules of rejection do not apply. Transplantation 54:694–704

    Article  CAS  PubMed  Google Scholar 

  16. Stulting RD, Waring GO III, Bridges WZ et al (1988) Effect of donor epithelium on corneal transplant survival. Ophthalmology 95:803–812

    CAS  PubMed  Google Scholar 

  17. Hori J, Streilein JW (2001) Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 42:720–726

    CAS  PubMed  Google Scholar 

  18. Maumenee A (1951) The influence of donor-recipient sen-sitization on corneal grafts. Am J Ophthalmol 34:142–152

    CAS  PubMed  Google Scholar 

  19. Khodadoust AA, Silverstein AM (1976) Induction of corneal graft rejection by passive cell transfer. Invest Ophthalmol 15:89–95

    CAS  PubMed  Google Scholar 

  20. Khodadoust AA, Silverstein AM (1969) Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol 8:180–195

    CAS  PubMed  Google Scholar 

  21. Hegde S, Beauregard C, Mayhew E et al (2005) CD4(+) T-cell-mediated mechanisms of corneal allograf rejection: role of Fas-induced apoptosis. Transplantation 79:23–31

    Article  CAS  PubMed  Google Scholar 

  22. Ayliffe W, Alam Y, Bell EB et al (1992) Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol 76:602–606

    Article  CAS  PubMed  Google Scholar 

  23. He YG, Ross J, Niederkorn JY (1991) Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 32:2723–2728

    CAS  PubMed  Google Scholar 

  24. Niederkorn JY, Stevens C, Mellon J et al (2006) CD4+ T-Cell-independent rejection of corneal allografts. Transplantation 81:1171–1178

    Article  PubMed  Google Scholar 

  25. Ksander BR, Sano Y, Streilein JW (1996) Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transpl Immunol 4:49–52

    Article  CAS  PubMed  Google Scholar 

  26. Niederkorn J Y, Stevens C, Mellon J et al (2006) Differential roles of CD8+ and CD8- T lymphocytes in corneal allograft rejection in ‘high-risk’ hosts. Am J Transplant 6:705–713

    Article  CAS  PubMed  Google Scholar 

  27. Salisbury JD, Gebhardt BM (1981) Blood group antigens on human corneal cells demonstrated by immunoperoxi-dase staining. Am J Ophthalmol 91:46–50

    CAS  PubMed  Google Scholar 

  28. Hegde S, Mellon JK, Hargrave SL et al (2002) Effect of alloantibodies on corneal allograft survival. Invest Ophthalmol Vis Sci 43:1012–1018

    PubMed  Google Scholar 

  29. Hegde S, Niederkorn JY (2000) The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci 41:3341–3347

    CAS  PubMed  Google Scholar 

  30. Holan V, Vitova A, Krulova M et al (2005) Susceptibility of corneal allografts and xenografts to antibody-mediated rejection. Immunol Lett 100:211–213

    Article  CAS  PubMed  Google Scholar 

  31. Goslings WR, Yamada J, Dana MR et al (1999) Corneal transplantation in antibody-deficient hosts. Invest Ophthalmol Vis Sci 40:250–253

    CAS  PubMed  Google Scholar 

  32. Claerhout I, Kestelyn P, Debacker V et al (2004) Role of natural killer cells in the rejection process of corneal allografts in rats. Transplantation 77:676–682

    Article  PubMed  Google Scholar 

  33. Mayer K, Reinhard T, Reis A et al (2003) Differential contribution of natural killer cells to corneal graft rejection in 3-week-old versus mature rats. Transplantation 76:578–582

    Article  PubMed  Google Scholar 

  34. Apte RS, Niederkorn JY (1996) Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 156: 2667–2673

    CAS  PubMed  Google Scholar 

  35. Beauregard C, Stevens C, Mayhew E et al (2005) Cutting edge: atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J Immunol 174:6577–6581

    CAS  PubMed  Google Scholar 

  36. Flynn TH, Ohbayashi M, Ikeda Y et al (2007) Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea. Invest Ophthalmol Vis Sci 48:4044–4049

    Article  PubMed  Google Scholar 

  37. Plskova J, Duncan L, Holan V et al (2002) The immune response to corneal allograft requires a site-specific draining lymph node. Transplantation 73:210–215

    Article  PubMed  Google Scholar 

  38. Yamagami S, Dana MR (2001) The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 42:1293–1298

    CAS  PubMed  Google Scholar 

  39. Ayliffe W, McLeod D, Hutchinson IV (1992) The effect of blood transfusions on rat corneal graft survival. Invest Ophthalmol Vis Sci 33:1974–1978

    CAS  PubMed  Google Scholar 

  40. Ishii N, Aoki I, Ishii Thet al (1988) Suppressor T cells in mice made unresponsive to skin allografts. J Invest Dermatol 91:333–335

    Article  CAS  PubMed  Google Scholar 

  41. Chen L, Hamrah P, Cursiefen C et al (2004) Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 10:813–815

    Article  CAS  PubMed  Google Scholar 

  42. Cursiefen C, Cao J, Chen L et al (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 45:2666–2673

    Article  PubMed  Google Scholar 

  43. McKinney EC, Streilein JW (1989) On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J Immunol 143:1560–1564

    CAS  PubMed  Google Scholar 

  44. Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7:354–359

    Article  CAS  PubMed  Google Scholar 

  45. Streilein JW (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3:879–889

    Article  CAS  PubMed  Google Scholar 

  46. Niederkorn JY (2006) Anterior chamber-associated immune deviation and its impact on corneal allograft survival. Curr Opin Organ Transplant 11:360–365

    Article  Google Scholar 

  47. Stuart PM, Griffith TS, Usui N et al (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99:396–402

    Article  CAS  PubMed  Google Scholar 

  48. Yamagami S, Kawashima H, Tsuru Thet al (1997) Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64:1107–1111

    Article  CAS  PubMed  Google Scholar 

  49. Hori J, Wang M, Miyashita M et al (2006) B7–H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 177:5928–5935

    CAS  PubMed  Google Scholar 

  50. Shen L, Jin Y, Freeman GJ et al (2007) The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol 179:3672–3679

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UT Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX, 75390-9057, USA

    Jerry Y. Niederkorn

Authors
  1. Jerry Y. Niederkorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Eye Hospital, Killianstraβe 5, Freiburg, 79106, Germany

    Thomas Reinhard (Professor and Chairman) (Professor and Chairman)

  2. Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, United Kingdom

    Frank Larkin

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Niederkorn, J.Y. (2010). Immune Privilege of Corneal Allografts. In: Reinhard, T., Larkin, F. (eds) Cornea and External Eye Disease. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85544-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-85544-6_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-85543-9

  • Online ISBN: 978-3-540-85544-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation